{"rows":[{"id":5793,"title":"Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigs","authors":"CA Madsen, M. Navarro, E. Kolesnik, D. Kazani, V. Shalgunov, M. Zabrocki, A. Nasser, D. Luethi, F. Holze, M.E. Liechti, S.S. Johansen, M.K.K. Nielsen, H.D. Hansen, G.M. Knudsen","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106824","pubmed_id":null,"openalex_id":"https://openalex.org/W7118016845","source_url":"https://doi.org/10.1016/j.nsa.2025.106824","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:13","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106824","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2025.106824","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106824","source_url":"https://doi.org/10.1016/j.nsa.2025.106824","doi":"10.1016/j.nsa.2025.106824","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4178,"title":"Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin","authors":"E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2026.106904","pubmed_id":null,"openalex_id":"https://openalex.org/W7161898772","source_url":"https://doi.org/10.1016/j.nsa.2026.106904","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Pharmacology,Clinical Trial,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2026.106904","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2026.106904","source_url":"https://doi.org/10.1016/j.nsa.2026.106904","doi":"10.1016/j.nsa.2026.106904","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4177,"title":"Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study","authors":"I. Totomanova, E.C.H.M. Haijen, P.P.M. Hurks, NL Mason, JG Ramaekers, K.P.C. Kuypers","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2026.106942","pubmed_id":null,"openalex_id":"https://openalex.org/W7161827243","source_url":"https://doi.org/10.1016/j.nsa.2026.106942","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Microdosing","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2026.106942","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2026.106942","source_url":"https://doi.org/10.1016/j.nsa.2026.106942","doi":"10.1016/j.nsa.2026.106942","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4176,"title":"Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults","authors":"Y. Ge, T.P. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, F.M. Ponteduro, N. Khalil, S. Fenn-Moltu, NA Puts, E. Daly, D.G.M. Murphy, G.M. McAlonan, D. Batalle","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2026.106906","pubmed_id":null,"openalex_id":"https://openalex.org/W7161826543","source_url":"https://doi.org/10.1016/j.nsa.2026.106906","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2026.106906","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2026.106906","source_url":"https://doi.org/10.1016/j.nsa.2026.106906","doi":"10.1016/j.nsa.2026.106906","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4160,"title":"Electrical brain changes following psilocybin administration in sprague-dawley rats","authors":"B. Richardson, V. Bruno, J. O'Byrne, G. Gobbi","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106819","pubmed_id":null,"openalex_id":"https://openalex.org/W7118013054","source_url":"https://doi.org/10.1016/j.nsa.2025.106819","substance_tags":"psilocybin","topic_tags":"Pharmacology,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106819","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106819","source_url":"https://doi.org/10.1016/j.nsa.2025.106819","doi":"10.1016/j.nsa.2025.106819","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4159,"title":"Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people","authors":"T. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, N. Khalil, G. Ivin, E. Daly, NA Puts, D.G.M. Murphy, G.M. McAlonan","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.105782","pubmed_id":null,"openalex_id":"https://openalex.org/W7118011913","source_url":"https://doi.org/10.1016/j.nsa.2025.105782","substance_tags":"psilocybin","topic_tags":"Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105782","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105782","source_url":"https://doi.org/10.1016/j.nsa.2025.105782","doi":"10.1016/j.nsa.2025.105782","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4158,"title":"Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial","authors":"L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.105779","pubmed_id":null,"openalex_id":"https://openalex.org/W7118005769","source_url":"https://doi.org/10.1016/j.nsa.2025.105779","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105779","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105779","source_url":"https://doi.org/10.1016/j.nsa.2025.105779","doi":"10.1016/j.nsa.2025.105779","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4157,"title":"The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial","authors":"L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106572","pubmed_id":null,"openalex_id":"https://openalex.org/W7118005328","source_url":"https://doi.org/10.1016/j.nsa.2025.106572","substance_tags":"psilocybin","topic_tags":"Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106572","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106572","source_url":"https://doi.org/10.1016/j.nsa.2025.106572","doi":"10.1016/j.nsa.2025.106572","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4156,"title":"Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model","authors":"I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106393","pubmed_id":null,"openalex_id":"https://openalex.org/W7117971173","source_url":"https://doi.org/10.1016/j.nsa.2025.106393","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Toxicity","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106393","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106393","source_url":"https://doi.org/10.1016/j.nsa.2025.106393","doi":"10.1016/j.nsa.2025.106393","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4155,"title":"An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes","authors":"N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106821","pubmed_id":null,"openalex_id":"https://openalex.org/W7117964120","source_url":"https://doi.org/10.1016/j.nsa.2025.106821","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106821","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106821","source_url":"https://doi.org/10.1016/j.nsa.2025.106821","doi":"10.1016/j.nsa.2025.106821","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4154,"title":"The role of 5-HT2A receptors in sleep architecture and memory consolidation in the animal model","authors":"K. Aleksič","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106729","pubmed_id":null,"openalex_id":"https://openalex.org/W7117962834","source_url":"https://doi.org/10.1016/j.nsa.2025.106729","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Animal Study","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106729","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2025.106729","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106729","source_url":"https://doi.org/10.1016/j.nsa.2025.106729","doi":"10.1016/j.nsa.2025.106729","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4153,"title":"Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression","authors":"L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106390","pubmed_id":null,"openalex_id":"https://openalex.org/W7117961846","source_url":"https://doi.org/10.1016/j.nsa.2025.106390","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Treatment-Resistant Depression,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106390","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106390","source_url":"https://doi.org/10.1016/j.nsa.2025.106390","doi":"10.1016/j.nsa.2025.106390","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2001,"title":"Preclinical evaluation of psilocybin as an anti-inflammatory agent","authors":"N. Martínez-Álvarez, I. Erkizia-Santamaría, A. Tomás-Alvarado, A.M. Erdozain, J.J. Meana, J.E. Ortega","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.105853","pubmed_id":null,"openalex_id":"https://openalex.org/W7118009135","source_url":"https://doi.org/10.1016/j.nsa.2025.105853","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Pharmacology,Animal Study,Toxicity,Inflammation","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105853","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105853","source_url":"https://doi.org/10.1016/j.nsa.2025.105853","doi":"10.1016/j.nsa.2025.105853","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2000,"title":"Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music","authors":"M. Benes, D. Gregus, P. Adamek, T. Páleníček, J. Horacek","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106823","pubmed_id":null,"openalex_id":"https://openalex.org/W7118007847","source_url":"https://doi.org/10.1016/j.nsa.2025.106823","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Healthy Volunteers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106823","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106823","source_url":"https://doi.org/10.1016/j.nsa.2025.106823","doi":"10.1016/j.nsa.2025.106823","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1998,"title":"Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults","authors":"O. Ollari, T.P. Whelan, C.L. Ellis, N. Khalil, F. Moruzzi, D.G.M. Murphy, E. Daly, L. Mason, N. Puts, G.M. McAlonan","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2026.106903","pubmed_id":null,"openalex_id":"https://openalex.org/W7161753513","source_url":"https://doi.org/10.1016/j.nsa.2026.106903","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Brain Imaging,Biomarkers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2026.106903","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2026.106903","source_url":"https://doi.org/10.1016/j.nsa.2026.106903","doi":"10.1016/j.nsa.2026.106903","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1997,"title":"Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice","authors":"Sellitti F., Weber C., Tamura É., Li Z., Thomann J., Luethi D., Simmler L.D.","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106574","pubmed_id":null,"openalex_id":"https://openalex.org/W7118009596","source_url":"https://doi.org/10.1016/j.nsa.2025.106574","substance_tags":"psilocybin,psilocin","topic_tags":"Animal Study","study_type":"Animal Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106574","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.nsa.2025.106574","source_url":"https://doi.org/10.1016/j.nsa.2025.106574","doi":"10.1016/j.nsa.2025.106574","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1996,"title":"Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin","authors":"I. Totomanova, E.C.H.M. Haijen, Petra P. M. Hurks, NL Mason, K.P.C. Kuypers","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106822","pubmed_id":null,"openalex_id":"https://openalex.org/W7117971009","source_url":"https://doi.org/10.1016/j.nsa.2025.106822","substance_tags":"psilocybin","topic_tags":"Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106822","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106822","source_url":"https://doi.org/10.1016/j.nsa.2025.106822","doi":"10.1016/j.nsa.2025.106822","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1995,"title":"Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans","authors":"A. O'shea, JG Ramaekers, R. Schreiber, J.J. Briedé, J. Krauskopf, N. Mason, M.C.T. Verheijen","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106576","pubmed_id":null,"openalex_id":"https://openalex.org/W7117995674","source_url":"https://doi.org/10.1016/j.nsa.2025.106576","substance_tags":"psilocybin","topic_tags":"Pharmacology,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106576","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106576","source_url":"https://doi.org/10.1016/j.nsa.2025.106576","doi":"10.1016/j.nsa.2025.106576","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1994,"title":"Behavioral and neuronal effects of psilocybin in mice","authors":"C. Weber, F. Sellitti, L. Ziming, J. von Arx, L.D. Simmler","journal":"Neuroscience Applied","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.nsa.2025.106575","pubmed_id":null,"openalex_id":"https://openalex.org/W7118002886","source_url":"https://doi.org/10.1016/j.nsa.2025.106575","substance_tags":"psilocybin","topic_tags":"Pharmacology,Animal Study,Toxicity","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.106575","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106575","source_url":"https://doi.org/10.1016/j.nsa.2025.106575","doi":"10.1016/j.nsa.2025.106575","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4475,"title":"Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression","authors":"Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/j.nsa.2025.105421","pubmed_id":null,"openalex_id":"https://openalex.org/W4408526135","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:24","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105421","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105421","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","doi":"10.1016/j.nsa.2025.105421","pmid":"","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":57,"page":1,"per_page":20,"pages":3,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Neuroscience Applied","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}